Zydus Lifesciences Ltd. Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

Zydus Lifesciences Ltd. is a leading pharmaceutical company in India that specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical products. In this article, we will provide a comprehensive analysis of Zydus Lifesciences Ltd. stock from a long-term investor's perspective. We will cover various topics such as share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders.

Zydus Lifesciences Ltd. Share Price:

Zydus Lifesciences Ltd.'s share price is a key indicator of investor sentiment towards the company. The share price is influenced by various factors such as the company's financial performance, global economic conditions, and market sentiment. Long-term investors can use our pre-built screening tools to analyze Zydus Lifesciences Ltd.'s share price and identify any trends or patterns. The company's share price has shown a stable trend over the past few years, reflecting the company's solid financial position and growth prospects.

Zydus Lifesciences Ltd. Balance Sheet:

Zydus Lifesciences Ltd.'s balance sheet provides crucial information about its financial health. The company's assets include fixed assets, investments, and other assets, while liabilities include loans, borrowings, and other liabilities. Equity includes share capital, reserves, and surplus. Long-term investors can use our pre-built screening tools to analyze Zydus Lifesciences Ltd.'s balance sheet and identify any red flags. The company's balance sheet has shown a stable trend over the past few years, reflecting the company's solid financial position and growth prospects.

Zydus Lifesciences share capital trends  

Its share capital of Rs 102.40 crore in March 2020 has slightly come down over the period till March 2024 to Rs 100.60 crore only. This shows that there has been a relatively small number of changes in the equity structure over these years.

Zydus Lifesciences Keeps Profit Growth  

From the consolidated balance sheet at March 2020 to the balance sheet at March 2024, Zydus Lifesciences’ reserves have risen from Rs 11,157.80 crore to Rs 15,615.90 crore. This is evident of high retained earnings which acts as a backing to the projection of the financial strength of the company.

Zydus Lifesciences Debt Charges  

The creditors at first reduced it from Rs 1,511 crore in March 2020 to Rs 126.40 crore in March 2022 but rose to Rs 5,555.40 crore in March 2024. Such a rise may be attributed to new funding for development or investment in plant and equipment.

Zydus Lifesciences Asset Makeup  

Consolidated total assets of the company increased to Rs 27,496.40 crore in March 2024 from Rs 18,155.50 crore in March 2020 mainly due to increase in investment and current assets. More encouragingly, it increased from Rs 4,897.50 crore in the CR period March, 2022 to Rs 7,283 crore in the ER period of March, 2024, which underlines strategic asset investment.

Zydus Lifesciences total Current liabilities  

For current liabilities there were variations with an amount of Rs 5,163.50 crore for March 2021 and Rs 4,392 crore for March 2024. This I presume points to the work towards the efficient management of short term liabilities.

This analysis is all based on the balance sheet of Zydus Lifesciences at a standalone level. 

Regarding the pharmaceuticals sector, debt levels and reserve growth indicators could prove valuable to investors intending to screen acquisition stocks.

Zydus Lifesciences Ltd. Annual Report:

Zydus Lifesciences Ltd. releases an annual report every year, which provides detailed information about the company's financial performance, strategic initiatives, and future plans. The annual report includes a letter from the Chairman, financial statements, and management discussion and analysis. Long-term investors can download Zydus Lifesciences Ltd.'s annual report from our website and use it to make informed investment decisions. The annual report provides valuable insights into the company's operations and financial performance.

Zydus Lifesciences Ltd. Dividend:

Zydus Lifesciences Ltd. has a consistent dividend payout history. The company has paid dividends in every year, reflecting its commitment to rewarding shareholders. Long-term investors should consider this when evaluating Zydus Lifesciences Ltd.'s stock. Our pre-built screening tools can be used to analyze the company's dividend history and identify any trends or patterns.

Zydus Lifesciences Ltd. Quarterly Results:

Zydus Lifesciences Ltd. releases its quarterly results every three months. The quarterly results provide information about the company's revenue, earnings, and expenses. Long-term investors can use our pre-built screening tools to analyze Zydus Lifesciences Ltd.'s quarterly results and identify any trends or patterns. The quarterly results are an important indicator of the company's financial health and performance.

Zydus Lifesciences Ltd. Stock Price:

The stock price of Zydus Lifesciences Ltd. is affected by various factors such as the company's financial performance, global economic conditions, and market sentiment. Long-term investors can use our pre-built screening tools to track Zydus Lifesciences Ltd.'s stock price and identify potential buying opportunities. The stock price of Zydus Lifesciences Ltd. has shown a stable trend over the past few years, reflecting the company's solid financial performance and growth prospects.

Zydus Lifesciences Ltd. Price Chart:

A price chart provides a visual representation of a company's stock price over a period of time. Long-term investors can use our pre-built screening tools to analyze Zydus Lifesciences Ltd.'s price chart and identify any trends or patterns. The price chart shows that the stock price of Zydus Lifesciences Ltd. has shown a stable trend over the past few years, reflecting the company's solid financial performance and growth prospects.

Zydus Lifesciences Ltd. News:

Keeping up to date with the latest news about Zydus Lifesciences Ltd. is important for investors. Our website provides the latest news about Zydus Lifesciences Ltd. from various sources such as financial news websites and social media. Long-term investors can use this information to make informed investment decisions.

Zydus Lifesciences Ltd. Concall:

Zydus Lifesciences Ltd. holds conference calls with analysts and investors to discuss its financial performance and future plans. Long-term investors can listen to Zydus Lifesciences Ltd.'s concall and use the information provided to make informed investment decisions. Our website provides information about upcoming concalls and links to listen to past concalls.

Zydus Lifesciences Ltd. Transcripts:

Transcripts of Zydus Lifesciences Ltd.'s concalls are available on our website. Long-term investors can download the transcripts and use them to analyze the company's financial performance and future plans. The transcripts provide valuable insights into the company's operations and financial performance.

Zydus Lifesciences Ltd. Investor Presentations:

Zydus Lifesciences Ltd. provides investor presentations on its website. These presentations provide information about the company's financial performance, strategic initiatives, and future plans. Long-term investors can download Zydus Lifesciences Ltd.'s investor presentations from our website and use them to make informed investment decisions. The investor presentations provide valuable insights into the company's operations and financial performance.

Zydus Lifesciences Ltd. Promoters:

Promoters are individuals or entities that have a significant stake in a company. Zydus Lifesciences Ltd.'s promoters include the Zydus family. Long-term investors can use our pre-built screening tools to analyze Zydus Lifesciences Ltd.'s promoter holdings and identify any potential conflicts of interest. The promoter holdings of Zydus Lifesciences Ltd. are relatively stable, which is a positive sign for long-term investors.

Zydus Lifesciences Ltd. Shareholders:

Zydus Lifesciences Ltd. has a large number of shareholders, including institutional investors and individual investors. Long-term investors can use our pre-built screening tools to analyze Zydus Lifesciences Ltd.'s shareholder base and identify any potential risks or opportunities. The shareholder base of Zydus Lifesciences Ltd. is diverse, which is a positive sign for long-term investors.

Zydus Lifesciences Ltd. Premium Features:

Our website provides premium features tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools can help long-term investors make better investment decisions by providing more detailed insights into the company's financial performance and valuation.

Zydus Lifesciences Limited ROCE

The Return on Capital Employed (ROCE) is an important financial ratio used to assess the profitability and efficiency of a company. For Zydus Lifesciences Limited, the ROCE ratio can be found in the financials table or ratio section of this page. ROCE measures the return generated from the capital employed in the business, including both equity and debt. By analyzing the ROCE, investors can gauge the company's ability to generate profits from its capital investments. It provides insight into the company's efficiency in utilizing its resources to generate returns for shareholders.

Zydus Lifesciences Limited EBITDA

EBITDA, an acronym for Earnings Before Interest, Taxes, Depreciation, and Amortization, is a metric commonly used to assess a company's operating performance. In the case of Zydus Lifesciences Limited, the EBITDA ratio is available in the financials table or ratio section on this page. EBITDA provides a snapshot of a company's profitability by excluding non-operating expenses and accounting considerations such as interest, taxes, and depreciation. It allows investors and analysts to evaluate the company's core operating profitability and compare it with industry peers.

Zydus Lifesciences Limited DPS

Dividends per Share (DPS) is a financial metric that represents the amount of dividend distributed to each shareholder on a per-share basis. This information is available in the financials table or ratio section on this page for Zydus Lifesciences Limited. DPS is an important indicator for investors seeking regular income from their investments. It reflects the company's willingness and ability to distribute profits to shareholders. By comparing DPS over time and across similar companies, investors can assess the stability and growth of dividend payments.

Zydus Lifesciences Limited EPS

Earnings per Share (EPS) is a fundamental financial metric that measures the profitability of a company on a per-share basis. Zydus Lifesciences Limited's EPS can be found in the financials table or ratio section on this page. EPS is commonly used by investors to evaluate a company's performance and to compare it with competitors. It indicates the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally desirable as it signifies a larger portion of earnings available to shareholders.